Advertisement

Radiation Protection in Pediatric Nuclear Medicine

Chapter

Abstract

The practice of pediatric nuclear medicine requires attention to detail with regard to radiation protection of the health professionals involved in acquiring the studies, the patients, and their families. Since performance of the studies may entail a more hands-on approach, particularly in very small children, those involved in acquiring the studies often need to be closer to the patient than would be the case in adult nuclear medicine. For example, a bone scan in a smaller child may require two technologists where one helps with the immobilization of the patient while the other acquires the study. In this instance, not only are two technologists involved with a single patient, but one may need to hold the radioactive patient in order to acquire the required view to make the clinical decision. In addition, if sedation or anesthesia is necessary to complete the study, other health professionals such as nurses and anesthesiologists may need to be in the imaging room with the radioactive patient. Lastly, there may be some studies such as ictal brain SPECT where the patient is injected remotely from the nuclear medicine clinic which may present unique radiation protection considerations.

Keywords

Radiation Protection Radioactive Material Radiation Safety Nuclear Regulatory Commission License Application 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Committee to Assess Health Risks from Exposure to Low Levels of Ionizing Radiation, National Research Council. Health risks from exposure to low levels of ionizing radiation: BEIR VII phase 2. Washington, DC: National Research Council of the National Academies; 2006.Google Scholar
  2. 2.
    U.S. Nuclear Regulatory Commission. Code of Federal Regulations. Standards for protection against radiation. Washington, DC: U.S. Government Printing Office: 10 CFR Part 20; 2002.Google Scholar
  3. 3.
    U.S. Nuclear Regulatory Commission. Code of Federal Regulations. Medical use of byproduct material. Washington, DC: U.S. Government Printing Office: 10 CFR Part 35; 2002.Google Scholar
  4. 4.
    Consolidated Guidance About Materials Licenses: Program - Specific Guidance About Medical Use Licenses. U.S. Nuclear Regulatory Commission. NUREG-1556, Volume 9, Rev.1 - Program Specific Guidance about Medical Licensees. 2005.Google Scholar
  5. 5.
    Consolidated Guidance About Materials Licenses: Program-Specific Guidance About Licenses of Broad Scope. U.S. Nuclear Regulatory Commission. NUREG-1556, Volume 11 - Program-Specific Guidance About Licenses of Broad Scope. 1999.Google Scholar
  6. 6.
    Siegel JA. A guide for diagnostic nuclear medicine. Reston: Society of Nuclear Medicine; 2001.Google Scholar
  7. 7.
    U.S. Nuclear Regulatory Commission. Code of federal regulations. Notices, instructions and reports to workers: inspection and investigations. Washington, DC: U.S. Government Printing Office: 10 CFR Part 19; 1973.Google Scholar
  8. 8.
    ICRP Statement on Tissue Reactions, ICRP ref 4825-3093-1 464, International Commission on Radiation Protection, Ottawa. 2011.Google Scholar
  9. 9.
    Bouffler S, Ainsbury E, Gilvin P, Harrison J. Radiation-induced cataracts: the health protection agency’s response to the ICRP statement on tissue reactions and recommendation on the dose limit for the eye lens. J Radiol Prot. 2012;32:479–88.PubMedCrossRefGoogle Scholar
  10. 10.
    Sans Merce M, Ruiz N, Barth I, Carnicer A, Donadille L, Ferrari P, Fulop M, Ginjaume M, Gualdrini G, Krim S, Mariotti F, Ortega X, Rimpler A, Vanhavere F, Baechler S. Extremity exposure in nuclear medicine: preliminary results of a European study. Radiat Prot Dosimetry. 2011;144:515–20.PubMedCrossRefGoogle Scholar
  11. 11.
    Guidelines for Patients Receiving I-131 Radiotherapy Treatment. Society of Nuclear Medicine and Molecular Imaging. http://interactive.snm.org/index.cfm?PageID=11220. 2011.
  12. 12.
    Sisson JC, Freitas J, McDougall IR, Dauer LT, Hurley JR, Brierley JD, Edinboro CH, Rosenthal D, Thomas MJ, Wexler JA, Asamoah E, Avram AM, Milas M, Greenlee C. Radiation safety in the treatment of patients with thyroid diseases by radioiodine 131I: practice recommendations of the American Thyroid Association. Thyroid. 2011;21:335–46.PubMedCrossRefGoogle Scholar
  13. 13.
    Instructions Concerning Prenatal Radiation Exposure. U.S. Nuclear Regulatory Commission. NUREG-18.3. 1999.Google Scholar
  14. 14.
    Gelfand MJ, Parisi MT, Treves ST. Pediatric radiopharmaceutical administered doses: 2010 North American Consensus guidelines. J Nucl Med. 2011;52:318–22.PubMedCrossRefGoogle Scholar
  15. 15.
    Lassmann M, Biassoni L, Monsieurs M, Franzius C, Jacobs F. The new EANM paediatric dosage card. Eur J Nucl Med Mol Imaging. 2008;35:1748.PubMedCrossRefGoogle Scholar
  16. 16.
    Fahey FH, Treves ST, Adelstein SJ. Minimizing and communicating risk in pediatric nuclear medicine. J Nucl Med. 2011;52:1240–51.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  1. 1.Joint Program in Nuclear Medicine, Department of RadiologyHarvard Medical SchoolBostonUSA
  2. 2.Division of Nuclear Medicine and Molecular Imaging, Department of RadiologyBoston Children’s HospitalBostonUSA
  3. 3.Department of Radiation SafetyBoston Children’s HospitalBostonUSA

Personalised recommendations